देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
Zinc oxide
Ovelle Limited
D02AB
Zinc oxide
15 percent weight/weight
Ointment
Product not subject to medical prescription
Zinc products
Marketed
1994-11-10
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zinc 15% w/w Ointment 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Zinc Oxide 15% w/w. Excipients - Contains wool fat 4.25% w/w and cetostearyl alcohol 4.25% w/w For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Ointment A white ointment. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS An astringent and protective combination to protect irritated skin and to soothe minor skin irritations, superficial burns and wounds. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Apply as required after cleansing the affected area. If symptoms persist consult your doctor. 4.3 CONTRAINDICATIONS (1) Use as treatment of fungal infections. (2) Use in patients hypersensitive to any ingredients. (3) Use in large surface wounds or burns. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE For external use only. If there is no improvement or aggravation of the condition occurs consult your doctor. May cause local skin reaction. Wool fat and Cetostearyl alcohol may cause local skin reactions (e.g. stinging and contact dermatitis). Healthcare professionals should be aware that if this product comes into contact with dressings, clothing and bedding, the fabric can be easily ignited with a naked flame. Patients should be warned of this risk and advised to keep away from fire when using this product. This preparation may make skin and surfaces slippery 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION Zinc Oxide is incompatible with benzylpenicillin. 4.6 FERTILITY, PREGNANCY AND LACTATION Zinc Ointment is a monograph of the BP 1993 and as such H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ __ पूरा दस्तावेज़ पढ़ें